BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33627639)

  • 21. Small molecule 1a reduces FMRpolyG-mediated toxicity in in vitro and in vivo models for FMR1 premutation.
    Haify SN; Buijsen RAM; Verwegen L; Severijnen LWFM; de Boer H; Boumeester V; Monshouwer R; Yang WY; Cameron MD; Willemsen R; Disney MD; Hukema RK
    Hum Mol Genet; 2021 Aug; 30(17):1632-1648. PubMed ID: 34077515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential pathogenic mechanisms underlying Fragile X Tremor Ataxia Syndrome: RAN translation and/or RNA gain-of-function?
    Boivin M; Willemsen R; Hukema RK; Sellier C
    Eur J Med Genet; 2018 Nov; 61(11):674-679. PubMed ID: 29223504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome.
    Asamitsu S; Yabuki Y; Ikenoshita S; Kawakubo K; Kawasaki M; Usuki S; Nakayama Y; Adachi K; Kugoh H; Ishii K; Matsuura T; Nanba E; Sugiyama H; Fukunaga K; Shioda N
    Sci Adv; 2021 Jan; 7(3):. PubMed ID: 33523882
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FMR1 locus isoforms: potential biomarker candidates in fragile X-associated tremor/ataxia syndrome (FXTAS).
    Zafarullah M; Tang HT; Durbin-Johnson B; Fourie E; Hessl D; Rivera SM; Tassone F
    Sci Rep; 2020 Jul; 10(1):11099. PubMed ID: 32632326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium dysregulation and Cdk5-ATM pathway involved in a mouse model of fragile X-associated tremor/ataxia syndrome.
    Robin G; López JR; Espinal GM; Hulsizer S; Hagerman PJ; Pessah IN
    Hum Mol Genet; 2017 Jul; 26(14):2649-2666. PubMed ID: 28444183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).
    Tassone F; Iwahashi C; Hagerman PJ
    RNA Biol; 2004 Jul; 1(2):103-5. PubMed ID: 17179750
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Composition of the Intranuclear Inclusions of Fragile X-associated Tremor/Ataxia Syndrome.
    Ma L; Herren AW; Espinal G; Randol J; McLaughlin B; Martinez-Cerdeño V; Pessah IN; Hagerman RJ; Hagerman PJ
    Acta Neuropathol Commun; 2019 Sep; 7(1):143. PubMed ID: 31481131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.
    Wang JY; Hessl D; Schneider A; Tassone F; Hagerman RJ; Rivera SM
    JAMA Neurol; 2013 Aug; 70(8):1022-9. PubMed ID: 23753897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Pathophysiology of Fragile X-Associated Tremor/Ataxia Syndrome and Perspectives for Drug Development.
    Botta-Orfila T; Tartaglia GG; Michalon A
    Cerebellum; 2016 Oct; 15(5):599-610. PubMed ID: 27277287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TDP-43 suppresses CGG repeat-induced neurotoxicity through interactions with HnRNP A2/B1.
    He F; Krans A; Freibaum BD; Taylor JP; Todd PK
    Hum Mol Genet; 2014 Oct; 23(19):5036-51. PubMed ID: 24920338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the r(CGG) repeats that cause FXTAS with modularly assembled small molecules and oligonucleotides.
    Tran T; Childs-Disney JL; Liu B; Guan L; Rzuczek S; Disney MD
    ACS Chem Biol; 2014 Apr; 9(4):904-12. PubMed ID: 24506227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of fragile X-associated tremor ataxia.
    Berman RF; Willemsen R
    J Investig Med; 2009 Dec; 57(8):837-41. PubMed ID: 19574928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The fragile X-associated tremor ataxia syndrome.
    Tassone F; Hagerman R
    Results Probl Cell Differ; 2012; 54():337-57. PubMed ID: 22009361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite Expansion Diseases: Repeat Toxicity Found in Translation.
    Gao FB; Richter JD
    Neuron; 2017 Jan; 93(2):249-251. PubMed ID: 28103472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a Drosophila model of fragile X tremor/ataxia syndrome.
    Jin P; Duan R; Qurashi A; Qin Y; Tian D; Rosser TC; Liu H; Feng Y; Warren ST
    Neuron; 2007 Aug; 55(4):556-64. PubMed ID: 17698009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What has been learned from mouse models of the Fragile X Premutation and Fragile X-associated tremor/ataxia syndrome?
    Foote MM; Careaga M; Berman RF
    Clin Neuropsychol; 2016 Aug; 30(6):960-72. PubMed ID: 27355912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The neuropathological mechanism on guanine-rich repeat expansion diseases].
    Yabuki Y; Shioda N
    Nihon Yakurigaku Zasshi; 2023; 158(1):30-33. PubMed ID: 36596485
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induced expression of expanded CGG RNA causes mitochondrial dysfunction in vivo.
    Hukema RK; Buijsen RA; Raske C; Severijnen LA; Nieuwenhuizen-Bakker I; Minneboo M; Maas A; de Crom R; Kros JM; Hagerman PJ; Berman RF; Willemsen R
    Cell Cycle; 2014; 13(16):2600-8. PubMed ID: 25486200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age- and CGG repeat-related slowing of manual movement in fragile X carriers: A prodrome of fragile X-associated tremor ataxia syndrome?
    Shickman R; Famula J; Tassone F; Leehey M; Ferrer E; Rivera SM; Hessl D
    Mov Disord; 2018 Apr; 33(4):628-636. PubMed ID: 29389022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebellar Mild Iron Accumulation in a Subset of FMR1 Premutation Carriers with FXTAS.
    Rogers H; Ariza J; Monterrubio A; Hagerman P; Martínez-Cerdeño V
    Cerebellum; 2016 Oct; 15(5):641-4. PubMed ID: 27259564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.